13G Filing: Visium Asset Management and Sage Therapeutics, Inc. (SAGE)

Page 8 of 11

Page 8 of 11 SEC Filing


CUSIP No. 78667J108 Page
8
of 11 Pages
(iv) shared power to dispose or to direct disposition of:

1,893,009 shares

Gottlieb

(a) Amount Beneficially Owned:

By virtue of his position as the Managing
Member of JG Asset, Gottlieb may be deemed to beneficially own the 1,893,009 shares of the Companys Common Stock beneficially owned by JG Asset.

(b) Percent of Class:

5.9%

(c) Number of Shares as to which person has:
(i) sole power to vote or to direct vote:
None
(ii) shared power to vote or to direct vote:
1,893,009 shares
(iii) sole power to dispose or direct disposition of:
None
(iv) shared power to dispose or to direct disposition of:
1,893,009 shares

VAM, JG Asset and Gottlieb disclaim beneficial ownership as to the securities, except to the
extent of his or its pecuniary interests therein. Neither the filing of this Schedule nor any of its contents shall be deemed to constitute an admission that any of the other individual officers and members of VAM or JG Asset is, for any
purpose, the beneficial owner of any of the Securities.

Page 8 of 11 Pages

Follow Sage Therapeutics Inc. (NASDAQ:SAGE)

Page 8 of 11